PICTET ASSET MANAGEMENT LTD - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 143 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2016. The put-call ratio across all filers is 1.43 and the average weighting 0.0%.

Quarter-by-quarter ownership
PICTET ASSET MANAGEMENT LTD ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2016$1,446,000
+40.3%
157,126
+79.7%
0.01%
+25.0%
Q3 2016$1,031,000
-24.6%
87,4260.0%0.00%
-20.0%
Q2 2016$1,368,000
+52.3%
87,426
+70.1%
0.01%
+25.0%
Q1 2016$898,000
-39.0%
51,4000.0%0.00%
-33.3%
Q4 2015$1,472,000
-37.8%
51,400
-38.2%
0.01%
-40.0%
Q3 2015$2,368,000
-31.1%
83,200
+8.8%
0.01%
-28.6%
Q2 2015$3,436,00076,5000.01%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q3 2016
NameSharesValueWeighting ↓
Orbimed Advisors 6,171,440$54,802,0000.52%
Regal Investment Advisors LLC 161,600$1,435,0000.34%
Folger Hill Asset Management LP 396,315$3,519,0000.30%
SCHNEIDER CAPITAL MANAGEMENT CORP 181,900$1,615,0000.29%
Mirae Asset Global Investments Co., Ltd. 1,033,683$9,179,0000.17%
JW Asset Management, LLC 29,409$72,0000.05%
TCI Wealth Advisors, Inc. 9,516$85,0000.04%
GAM Holding AG 83,940$745,0000.03%
Freedom Investment Management, Inc. 63,032$560,0000.03%
Sterling Investment Advisors, Ltd. 5,000$44,0000.03%
View complete list of INSYS THERAPEUTICS INC NEW shareholders